| Typicality: | 0.409 |
| Saliency: | 0.372 |
| for the purpose | 5 | purpose |
| in dogs | 5 | location |
| by targeting circadian pathways | 2 | manner |
| drug → treat → obesity | 35 |
| drug → prevent → obesity | 5 |
| drug → manage → obesity | 3 |
| drug → fight → obesity | 3 |
| drug → reduce → obesity | 3 |
| negative | neutral | positive |
| 0.216 | 0.566 | 0.218 |
| Raw frequency | 49 |
| Normalized frequency | 0.372 |
| Modifier score | 0.500 |
| Perplexity | 31.842 |